Progress in healthcare doesn't happen by chance—it's driven by leaders who keep raising the bar. Congratulations to three of our leaders who were honored by the Healthcare Businesswomen’s Association for their impact across the industry. 💡 Heidi Seerden enables customers to deliver precision healthcare by understanding their needs, informing product development and leading teams with a focus on developing talent and fostering trust. 🔬 Julia Casey is a trusted enterprise leader who accelerates scientific innovation, strengthens diagnostic capabilities and advances precision medicine globally. 🌟 Tricia Clark is a respected enterprise leader who strengthens safety, environmental stewardship and fosters a culture where people feel seen, supported and inspired. Grateful to have leaders like Heidi, Tricia and Julia shaping what’s next in healthcare! #HBAimpact #AscendwithHBA #WomenInLeadership
About us
Every day millions of people feel the impact of our intelligent devices, advanced analytics and artificial intelligence. As a leading global medical technology and digital solutions innovator, GE HealthCare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. We embrace a culture of respect, transparency, integrity and diversity and we work to create a world where healthcare has no limits.
- Website
-
http://www.gehealthcare.com
External link for GE HealthCare
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Chicago
- Type
- Public Company
- Specialties
- Healthcare and Biotechnology
Locations
-
Primary
Get directions
-
Chicago, US
Employees at GE HealthCare
Updates
-
Theranostics is no longer emerging—it’s transforming cancer care. For decades, oncology has relied on three foundational pillars: surgery, chemotherapy and external beam radiation. Today, a fourth pillar is accelerating progress—theranostics—integrating diagnosis and treatment through molecular imaging to help deliver more precise, personalized care. On #WorldTheranosticsDay, we celebrate the thinkers, the history, the momentum and the patients whose care is being reshaped by precision. 📸 1937: A rare photo of Dr. Hertz (also known as the founding father of Theranostics). During early thyroid radioiodine research, their work emphasized the convergence of multiple scientific disciplines that pioneered nuclear medicine. 📸 1930s: Dr. Hertz, along with other Theranostics pioneers, in the original building of Massachusetts General Hospital. 📸 1940s: A newspaper article featuring Dr. Hertz (left) and his patient. Dr. Hertz predicted the future of the field: "Demand is expected in the fields of cancer and leukemia for other radioactive drugs." 📸 Present day: Barbara, Dr. Hertz’s daughter, points to a plaque reproducing Dr. Hertz's handwritten "Data Chart" from the first 29 patients treated for thyroid disease, photographed at Sheba Hospital.
-
-
Our hearts beat for innovation. 💜 At the American College of Cardiology Scientific Sessions, we showcased our latest advancements in cardiology and how they are helping clinicians deliver precision care. Check it out below! #ACC26
-
-
Putting more heart into cancer care—literally. We’re proud to take a leading industrial role in COMPASS, a five‑year consortium advancing precision cardio-oncology care across Europe. Together, we’re driving earlier detection of cardiotoxicity and enabling more personalized, AI‑powered treatment for cancer patients and survivors. 💜️
-
-
How are we shaping the future of radiology? By exploring potential new clinical pathways that could help improve patient outcomes! 💜 Building on 40+ years of shared scientific leadership, we’re proud to announce an expanded collaboration with Stanford Radiology to establish a Center of Excellence—incorporating a portfolio of research and innovation programs across several imaging modalities. These programs represent a coordinated effort to accelerate discovery, translation and clinical impact.
-
-
Globally, breast cancer screening guidelines increasingly recognize that a mammogram alone is not enough for many women—especially for those with dense breast tissue or elevated risk. Follow-up imaging like ultrasound and MRI, however, is often subject to cost sharing—creating barriers to timely diagnosis. In the U.S., approximately 1 in 5 women delay or skip recommended follow-up imaging due to cost. The signing of Gail’s Law in Wisconsin, home to 7,000+ GE HealthCare colleagues and contractors, puts the state among approximately 30 others in the U.S. that have enacted legislation to remove cost barriers to essential supplemental breast imaging. For colleagues like Tracey, this progress is deeply personal. Tracey Roberts, a Wisconsin-based GE HealthCare HR colleague, mother of two, Ironman Triathlete, PTO Board Member and all-around superwoman, learned she had breast cancer one month before COVID hit. Her diagnosis led to a mastectomy during the COVID outbreak, which meant no visitors other than her stuffed Kermit the Frog. “I am grateful to use my ‘powers for good’ by enabling my story to influence and guide other colleagues and patients. Gail’s Law resonates with me to help provide and secure access for others on this road.” #BreastCancerAwareness #GailsLaw
-
Imagine a platform that could give you a real-time, bird’s-eye view of every hospital bed and resource across a health service. Sounds futuristic, right? Powered by our Command Center technology, Bayside Health's ORA data platform has made this a reality across three of Bayside Health’s hospitals in Australia. This innovative technology is empowering these hospitals with real-time, system-wide insights to manage high patient volumes, streamline care coordination and create more proactive, connected care.
-
-
The future of imaging just leveled up. Our Photonova™ Spectra* photon-counting CT received U.S. 510(k) clearance—a significant step forward in imaging innovation. 🚀✨ Powered by our proprietary Deep Silicon detector technology, Photonova Spectra represents disciplined engineering designed to meaningfully advance precision CT, including impressive clarity, confidence and consistency through ultra-high definition spectral and spatial imaging. * Photonova Spectra is 510(k) cleared in the U.S. Not CE Marked. Not available in all markets.
-
Following its U.S. FDA 510(k) clearance and CE Mark, Allia Moveo has been on a worldwide install tour. 🌎 It’s latest stop: the first U.S. clinical installation of Allia Moveo at Baylor St. Luke’s Medical Center, a member of CommonSpirit Health, reinforcing its long-standing role as a national leader in adopting innovative technologies, and the first global educational installation at the University of South Florida’s Center for Advanced Medical Learning and Simulation (CAMLS) in the Tampa Medical & Research District, anchored by Tampa General Hospital and USF Health. This advanced simulation training enables students, faculty and clinicians to train on Allia Moveo’s advanced features, helping to accelerate early adoption. Congrats to these healthcare systems on the newest additions to their image-guided therapy suite. 💜
-
-
A handshake that moves healthcare forward. 🤝 Today marks the completed acquisition of Intelerad—accelerating the shift to cloud-first enterprise solutions to deliver precision care in high-growth settings. By integrating Intelerad's cloud-enabled software with our imaging technologies and AI capabilities, we can help enhance hospital efficiency, simplify complex workflows and better support patients and clinicians with precise, connected care across the continuum. Intelerad, welcome to GE HealthCare!